Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.7826
-0.0693 (-8.13%)
At close: Feb 13, 2026, 4:00 PM EST
0.7817
-0.0009 (-0.12%)
After-hours: Feb 13, 2026, 7:21 PM EST
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $6.37 million as of February 13, 2026. Its market cap has decreased by -27.47% in one year.
Market Cap
6.37M
Enterprise Value
7.53M
1-Year Change
-27.47%
Ranking
Category
Stock Price
$0.78
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $6.37M, a decrease of -98.47%. That is a compound annual growth rate of -44.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.37M | -26.17% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kiora Pharmaceuticals | 7.63M |
| Addex Therapeutics | 7.58M |
| Quoin Pharmaceuticals | 6.94M |
| Revelation Biosciences | 6.93M |
| PharmaCyte Biotech | 6.70M |
| Mustang Bio | 6.64M |
| Aptevo Therapeutics | 6.58M |
| Immuron | 6.46M |